Mirvie
PrivateLast Round
Series C
Sep 11, 2025
Est. Valuation
$155M
Total Funding Raised
$124.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mirvie is a biotechnology company that provides a medical diagnostic platform aimed at enhancing pregnancy safety through predictive tests and therapeutic solutions for effective pregnancy management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirvie Comparables
Compare Mirvie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sera Prognostics Inc. | 77% | |
| Trinity Biotech plc | 77% | |
| NX Prenatal Inc. | 76% |
Mirvie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 11, 2025 | ||||
| Series C | Aug 1, 2025 | ||||
| Grant | Aug 2, 2023 | ||||
| Debt | May 17, 2022 | ||||
| Series B | May 17, 2022 | ||||
Series A | Apr 27, 2021 |
Mirvie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B |
| Khosla Ventures | Series B, Series A |
| Portfolia | Series C |
| Gates Foundation | Grant |
| General Catalyst | Series B |
| Foresite Capital | Series B |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 31% MoM, reaching 4.7K.
- Sep 11, 2025
Raised $30M in Series C funding.
Mirvie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mirvie's valuation, stock price, and market status.
Is Mirvie a public or private company?
Mirvie is a private company.
What is the current stock price of Mirvie?
Mirvie is a private company with no public stock price. No recent secondary market data is available.
How much is Mirvie worth (valuation)?
Mirvie's valuation is estimated at $155.0M based on funding round data.
Can I buy Mirvie stock?
Mirvie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mirvie's last funding round?
Mirvie's most recent funding round was Series C on May 17, 2022.
Who are the main investors in Mirvie?
Key investors in Mirvie include Khosla Ventures, Decheng Capital, Mayfield Fund.
Will Mirvie IPO soon?
No public IPO plans have been announced for Mirvie.
How can I track Mirvie secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mirvie's secondary market activity and sign up for updates.